Get started

EXAS

Exact sciences corp Exact Sciences is a biotech stock that is overpriced. It's time to sell We touched 3 times the resistance line of a rising wedge pattern, impulsive wave pattern, and RSI 71 weekly overbought zone, the Q2 doesn't seem good. A leg down to 60$ retesting 69$ which is the resistance line of a rising wedge dropping below 40$ and based on the Q2 announcement either we drop hard to 25$ zone or we bounce back to 0.886 FIb 146$ zone which is a sign of a bearish bat pattern please take note that I'm not a financial advisor
NASDAQ:EXASShort
by MarketPax
3
Exact Sciences (NASDAQ: $EXAS) Breakout Off 0.786 Fib! 🎯Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
NASDAQ:EXASLong
by RedHotStocks
5
EXAS: Looks like a good growth company (Request: logicalBird1984Strong support at $90. However, down trend line also is strong. Weakening momentum as confirmed by the MACD indicator. Likely to see the down trendline holding down prices. Will have to see which Demand Zone (green boxes) provides the support. If it doesn't and it breaks below the $90 support, then it might fall to $75-$80. Definitely don't want to see it fall below $70. Now, if it breaks above the down trendline, then the next test will be the immediate Supply Zone (red box). If it is broken decisively, then the bulls are back in control. We can look to buy at the next retracement, likely around $100-105. I won't buy at this point because I'm not exactly bullish right now. But please do your own due diligence. Disclaimer: I'm not giving any trading and investing advice. I'm just sharing my chart observations. If you have any symbols that you'd like me to analyze, feel free to drop me a comment.
NASDAQ:EXAS
by leslieyimsm
8
Trading Idea - #ExactSciencesSELL ENTRY: 96.50 USD TARGET: 71.71 USD (26% profit) STOP: 111.30 Exact Sciences Corporation is a cancer screening and diagnosis company. The company focuses on the early detection and prevention of several forms of cancer. 1.) The price broke within few days through 3 support areas! CAUTION! 2.) The profitability of business activity is a major weakness of the company. 3.) The ratio of "company value to sales" places the company among the world's most expensive companies. Oberbought? 4.) The only positive thing I can say here, is that the share price is starting a mini-consolidation around the 97.50 USD support zone. I am afraid that this will not last for long time...
NASDAQ:EXASShort
by Traderherz-Analytics
Eros STX Global Corp 🧙Eros STX Global Corp is a film production and distribution company. It distributes its film content across multiplex chains and stand-alone theatres and broadcasts television content via tie-ups with channels such as ZEE TV and Star TV. The company also has a digital presence through its website; www.erosnow.com and an independent channel on Youtube. Geographically, it has a presence in India, North America, Europe and Rest of the world. The company primary revenue streams are derived from three channels: theatrical, television syndication and digital and ancillary. If you want not to miss ideas like this one ,🎯 subscribe and press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:EXASLong
by unfair_advantage
Stocks To Watch This WeekThe Bull Market is strong, but many stocks are extended and sentiment seems to be bullish. This video is my watchlist. Most of these names are at or near all time highs or multi year highs. There are 15 total stocks on this list. I also included 3 stocks with potential short squeeze opportunities. Many of these have IPO'd in the last few years and still have a growth story ahead of them. Know your time frame and risk tolerance, grab a pencil and paper and jot down the names that look interesting to you and then make the trade your own. Good Luck!
NASDAQ:LOVELong
by Jtacher51
3
EXAS daily 40% gains(STOCKS)before we kick start the update. your upvotes/subs are appreciated. Why get subbed to to me on Tradingview? -15+ years real live trading experience -TOP Author on TradingView -professional chart break downs -key levels -no junk on my charts -frequent updates -covering FX/crypto/US stocks -24/7 uptime so constant updates So without further due. Keep it short/simple and to the point. EXAS daily 40% gains(STOCKS) Gap fill play + strong seasonality April/May. 40% upside from here. good luck traders! get subbed to stay tuned for all the latest updates. also add likes to support my efforts, thank you.
NASDAQ:EXASLong
by ProjectSyndicate
1
The Exact Sciences Stock Chart Suggests Higher PricesExact Sciences shares are trading firmly above the uptrend line, which suggests that higher prices are likely to continue. This bullish view is further supported by the golden cross that was generated in July 2016. A golden cross is a bullish indicator that is produced when the faster 50-day moving average (highlighted in blue) crosses above the slower 200-day moving average (highlighted in red). This indicator is popular among investors because it is used to confirm that a bull market is development. This indicator was generated in July 2016, and there are no signs that this indicator will avert any time soon. This is because EXAS stock is currently trading above both moving averages that generated this bullish indicator. In January 2017, a bullish MACD cross was generated, indicating that the bullish momentum was once again propelling Exact Sciences stock. The path of least resistance is now geared toward higher prices. This indicator effectively confirmed that the consolidation wave had concluded, and served to suggest that a new impulse wave was in development.
NASDAQ:EXAS
by Jadtecnic